Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.730
-0.060 (-2.15%)
At close: May 26, 2026, 4:00 PM EDT
2.809
+0.079 (2.88%)
After-hours: May 26, 2026, 4:49 PM EDT
Anixa Biosciences Employees
Anixa Biosciences had 4 employees as of October 31, 2025. The number of employees decreased by 1 or -20.00% compared to the previous year.
Employees
4
Change (1Y)
-1
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$2,577,000
Market Cap
91.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 4 | -1 | -20.00% | 4 | 0 |
| Oct 31, 2024 | 5 | 0 | - | 5 | 0 |
| Oct 31, 2023 | 5 | 0 | - | 4 | 1 |
| Oct 31, 2022 | 5 | 0 | - | 4 | 1 |
| Oct 31, 2021 | 5 | 1 | 25.00% | 4 | 1 |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| ImmuCell | 73 |
| Oncolytics Biotech | 29 |
| Q32 Bio | 22 |
| LeonaBio | 19 |
| Edesa Biotech | 17 |
ANIX News
- 15 days ago - Anixa Biosciences’ lira-cel shows positive survival data in ovarian cancer - TheFly
- 15 days ago - Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy - PRNewsWire
- 25 days ago - Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV - PRNewsWire
- 27 days ago - Anixa Biosciences awarded patent for breast cancer vaccine in Mexico - TheFly
- 27 days ago - Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology - PRNewsWire
- 4 weeks ago - Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting - PRNewsWire
- 6 weeks ago - Anixa Biosciences Transcript: Water Tower Research Insights Conference - Transcripts
- 6 weeks ago - Anixa Biosciences Slides: Corporate presentation - Filings